Navigation Links
New Xarelto Lawsuit Alleges Manufacturers of Blood Thinner Made Misleading Claims to Promote Medication, Bernstein Liebhard LLP Reports
Date:8/13/2014

New York, NY (PRWEB) August 13, 2014

Xarelto lawsuits (http://www.injurybeacon.com/xarelto/lawsuit/) filed on behalf of individuals who were allegedly harmed by the blood thinner continue to mount in U.S. courts, Bernstein Liebhard LLP reports. Court documents pending in the U.S. District Court, Eastern District of New York indicate that a woman from Texas has filed a case against Johnson & Johnson and Bayer HealthCare that accuses the companies of making misleading claims in order to market Xarelto. According to the July 29th filing, the Plaintiff took Xarelto for just four months starting in March 2012, and suffered a life-threatening bleed that left her with severe and permanent injuries. (Case 1:14-cv-04524-DLI-MDG)

Among other things, the complaint alleges that Johnson & Johnson and Bayer failed to warn doctors and patients about the irreversible nature of Xarelto bleeding. It further alleges that the companies wrongly touted the drug as a superior alternative to warfarin, a blood thinner that has been in use for decades. Among other things, the Xarelto lawsuit also points out that the Defendants received a letter from the U.S. Food & Drug Administration’s (FDA) Office of Prescription Drug Promotion in July 2013 that characterized a Xarelto print ad as “false or misleading” because it minimized risks associated with the drug, and made a misleading claim regarding dosage adjustment.

“Our Firm has heard from a number of Xarelto patients who claim to have experienced life-threatening episodes of internal bleeding similar to the injuries alleged in this lawsuit,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering Xarelto case reviews to people who allegedly suffered serious injuries from the blood thinner, including intracranial hemorrhage, spinal and epidural hematoma, gastrointestinal hemorrhage, adrenal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or death.

Xarelto Litigation
According to a recent Reuters report, this claim is just one of several Xarelto lawusits pending in U.S. courts.* The Plaintiff in the New York case alleges that the manufacturers of the drug failed to warn that there is currently no approved antidote to reverse Xarelto bleeding. The complaint points out that while both warfarin and Xarelto can cause internal bleeding, this occurrence can be halted in warfarin patients via the administration of vitamin K.

In June, the Institute for Safe Medicine Practices reported that adverse events associated with the use of Xarelto are on the rise. According to data from the FDA, the agency received a total of 680 Xarelto adverse event reports in the first quarter of 2013. For the first time, reports of Xarelto complications outpaced those associated with Pradaxa, another blood thinner in the same class, according to the ISMP.**

Individuals who were allegedly harmed by Xarelto may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a Xarelto lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to schedule a free, no obligation case review.

*reuters.com/article/2014/06/14/us-bayer-suit-idUSKBN0EP0HW20140614, Reuters.com, June 14, 2014.
**ismp.org/quarterwatch/pdfs/2013Q1.pdf, Institute for Safe Medication Practices, May 7, 2014.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.injurybeacon.com
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/xarelto-lawsuit/xarelto-bleeding/prweb12092892.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. d'Oliveira & Associates Issues New Infographic on Xarelto Providing Current FDA and Medical Study Information
2. AffordRx Now Offering Xarelto Coupon Cards
3. Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation
4. Xarelto is Alleged to Cause Serious and Uncontrolled Internal Bleeding
5. Bernstein Liebhard LLP Launches New Xarelto Lawsuit Website for Individuals Allegedly Injured by Blood Thinner
6. Xarelto Lawsuits Filed Contend Wrongful Death and Internal Hemorrhaging Due to Blood Thinner
7. Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports
8. Rottenstein Law Group LLP Announces Launch of Xarelto Injury Website
9. Xarelto Lawsuit News: Report Finds Adverse Events For Xarelto Bleeding Side-Effects Outnumber Those For Pradaxa
10. Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports
11. Xarelto Lawsuit Page Launched By Wright & Schulte LLC In Response to Growing Litigation involving the Blood Thinner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... Sam & Associates Insurance Agency, ... and related services to residents of the region, is embarking on a charity ... and wild lands. , Endangered Species International is committed to ending the anthropogenic ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... California and Nevada and LABS, Inc., announced the future opening of a CLIA ... screening and serology testing used to determine the suitability of potential organ ...
(Date:3/22/2017)... FL (PRWEB) , ... March 22, 2017 , ... An ... mosquitoes could occasionally transmit HIV, reports Leslie Norins, MD, PhD. He says ... cases of domestically transmitted Zika virus and in new infections with HIV. ...
(Date:3/22/2017)... ... March 22, 2017 , ... Intrinsic Imaging, ... therapeutic experience and operational excellence in oncology clinical trials, proudly announces today that ... treatment of non-small cell lung cancer and small cell lung cancer. , Throughout ...
(Date:3/22/2017)... Oklahoma City, OK (PRWEB) , ... March 22, ... ... firm offering insurance and financial planning services to regional families and business owners, ... provide meaningful support to young people in the area. , A growing number ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... FALLS, N.J. , March 22, 2017  CANTEL MEDICAL ... Jorgen B. Hansen , President and CEO, will be presenting ... Conference at the Westin Grand Central Hotel in ... Wednesday, April 5, 2017 at 3:00 p.m. ET. In addition, ... day. A live audio webcast will be ...
(Date:3/22/2017)... JACKSONVILLE, Fla. , March 22, 2017 /PRNewswire/ ... clinical-stage immuno-oncology company specializing in the development of ... of cancer and metastatic disease, today announced that ... Industry conferences. Dr. Glynn Wilson ... an overview of the company,s business, clinical pipeline ...
(Date:3/22/2017)... 22, 2017 Hologic, Inc. (Nasdaq: ... acquisition of Cynosure, Inc., a leader in medical aesthetics ... "We are pleased to complete our acquisition ... Michael Davin and the entire Cynosure team to ... medical aesthetics market," said Steve MacMillan , Hologic,s ...
Breaking Medicine Technology: